Remdesivir-related cost-effectiveness and cost and resource use evidence in COVID-19: a systematic review

BACKGROUND: The coronavirus disease 2019 (COVID-19) pandemic has been a global health emergency since December 2019, leading to millions of deaths worldwide and placing significant pressures, including economic burden, on individual patients and healthcare systems. As of February 2022, remdesivir is...

Descripción completa

Detalles Bibliográficos
Autores principales: Murton, Molly, Drane, Emma, Jarrett, James, Cornely, Oliver A., Soriano, Alex
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9555695/
https://www.ncbi.nlm.nih.gov/pubmed/36224452
http://dx.doi.org/10.1007/s15010-022-01930-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9555695/
https://www.ncbi.nlm.nih.gov/pubmed/36224452
http://dx.doi.org/10.1007/s15010-022-01930-8

Ejemplares similares